When Did Viibryd Come Out? A Comprehensive Timeline
Hello there, curious minds! Today, we're going to dive into the world of psychiatry and explore the history of a popular antidepressant, Viibryd. If you're wondering, "When did Viibryd come out?" or want to know more about this medication, you've come to the right place. So, grab a cup of coffee, and let's embark on this informative journey together! Guys, explore more in Guides And Explainers and when did viibryd come out.
What is Viibryd?
Before we delve into the timeline, let's briefly understand what Viibryd is. Viibryd, also known by its generic name vilazodone, is a selective serotonin reuptake inhibitor (SSRI) and partial 5-HT1A receptor agonist. In layman's terms, it's an antidepressant that works by increasing the activity of serotonin in the brain. Serotonin is a neurotransmitter that's associated with mood regulation.
Now, let's get back to the question at hand: "When did Viibryd come out?"
The Birth of Viibryd: A Chronological Journey
The Early Years: Research and Development (2000s)
The story of Viibryd begins in the early 2000s when pharmaceutical companies started exploring new treatments for depression. The goal was to create a medication that could offer the same benefits as existing SSRIs but with fewer side effects. This led to the development of vilazodone, the active ingredient in Viibryd.
The FDA Approval: Viibryd's Big Break (2011)
After years of research and clinical trials, the U.S. Food and Drug Administration (FDA) finally approved Viibryd on August 23, 2011. This was a significant milestone in the history of this medication. The FDA approval meant that Viibryd was now available for prescription, offering patients and healthcare providers a new option in the treatment of major depressive disorder.
The Launch: Viibryd Hits the Market (2011)
Following its FDA approval, Viibryd was launched in the U.S. market in December 2011. The drug was introduced by the pharmaceutical company Forest Laboratories, now part of Actavis, a subsidiary of Teva Pharmaceutical Industries. Viibryd was initially available in 10 mg, 20 mg, and 40 mg tablets.
The Expansion: Viibryd Goes Global (2012 onwards)
After its successful launch in the U.S., Viibryd began to expand its reach globally. It received approval in several other countries, including Canada, Europe, and Australia. Today, Viibryd is available in many countries worldwide, providing a treatment option for major depressive disorder for patients and healthcare providers.
Viibryd Today: A Trusted Antidepressant
More than a decade after its launch, Viibryd continues to be a trusted and effective treatment option for major depressive disorder. It's prescribed by healthcare providers and used by patients around the world, helping to improve the lives of those affected by depression.
The Future of Viibryd: What's Next?
As research in psychiatry continues to evolve, we can expect to see new developments in the treatment of depression. While it's impossible to predict the future with certainty, one thing is clear: Viibryd will continue to play a significant role in the management of major depressive disorder, thanks to its unique mechanism of action and proven effectiveness.
And there you have it, folks! We've answered the question, "When did Viibryd come out?" and explored the fascinating journey of this medication. We hope you found this information helpful and insightful. Until next time, stay curious and keep exploring!